Get Daily Stock Reports

StockReport.com is a 7:00 PM newsletter with a pertinent stock report every day, plus the lates market news.

Stock of the Day: Tonix Pharmaceuticals

Tonix Pharmaceuticals
TNXP 90-day performance NASDAQ:TNXP Tonix Pharmaceuticals
Current Price
$14.98
-0.23 (-1.51%)
(As of 02/5/2025 04:00 PM ET)
30 Day Performance
5,099.58%
  
 
90 Day Performance
10,524.11%
  
 
1 Year Performance
41.86%
  
 
Market Capitalization
$2.80B
Price Target
$53.50
Net Income
-$116.66M

Tonix Pharmaceuticals Holding Corp. is a clinical-stage biopharmaceutical company headquartered in Chatham, New Jersey. The company was founded in 2007 and then later went public in 2013. Tonix Pharmaceuticals is led by Seth Lederman who has been CEO since co-founding the company. Mr. Lederman was an Associate Professor at Columbia University for more than 2 decades before venturing into the private sector. Tonix Pharmaceuticals is his second venture, the first was bought out after developing an effective treatment for colorectal cancer. The company operates through three facilities located in Massachusetts, Maryland, and Montana.

The two east-coast facilities are the R&D center and the Advanced Development Center while manufacturing is located in Montana. The Maryland facility is rated BSL-2 with some areas rated BSL-3 which allows for the handling of live viruses. The Massachusetts facility is intended to enhance the company’s R&D and analytics capabilities as well as facilitate vaccine production at the clinical trial scale. The Montana facility will support Phase III trials as well as the mass production of approved treatments.

Tonix Pharmaceuticals focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering across a wide spectrum of ailments and treatments. Among them is COVID-19 for which the company has several products in development.

Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The types of diseases the company targets are widely occurring but hard to treat so breakthroughs of any kind could be significant sources of income. The company has several candidates in pre-clinical and clinical trials with two standouts that are on track for FDA approval. Resilient, a treatment for Fibromyalgia, and Prevail, a treatment for long-COVID, entered Phase III and Phase II trials in 2022.

The immunology portfolio includes treatments for organ transplant rejection, autoimmunity, and cancer, and several in this group have shown efficacy against multiple indications. The company’s infectious disease pipeline includes several promising treatments for viruses afflicting the world today. The TNX-80 vaccine is intended to prevent smallpox and monkeypox while TNX-1840 and TNX-1850 are live virus vaccines to fight COVID-19, as will TNX-3500 and TNX-102, which are small molecule antiviral drugs.

Tonix Pharmaceuticals CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction including Resilient, which is in mid-Phase 3 development for the management of fibromyalgia. Other products in the pipeline are TNX-1900 which is in development for the prevention of migraine headaches and TNX-1300 which is designed to treat cocaine intoxication.

Read Full Report

More recent reports:

Halliburton logo
HAL 90-day price performance2/4/2025

Halliburton Stock Report

Halliburton Company is a multinational corporation that provides various services and products to the energy industry. Founded in 1919 and headquartered in Houston, Texas, the company operates in over 80 countries, with its primary business lines including drilling and evaluation, completion and production, hydraulic fracturing and other services.
Read Report ▸
Norfolk Southern logo
NSC 90-day price performance2/3/2025

Norfolk Southern Stock Report

Norfolk Southern Corp is a transportation company headquartered in Atlanta, Georgia, formed in 1982 after the merger of two competing railroads, the Norfolk and Western Railway and the Southern Railway. The company operates a major freight railroad network of over 19,000 miles of track across 22 states in the eastern United States. Norfolk Southern
Read Report ▸
Ares Capital logo
ARCC 90-day price performance2/2/2025

Ares Capital Stock Report

Ares Capital Corporation is a specialty finance provider offering small and mid-sized businesses customized financing solutions. Ares Capital Management LLC, a subsidiary of Ares Management Corporation, manages the company. ARCC specializes in acquisition, mezzanine debt, recapitalization, restructuring and leveraged buyout transactions. Ares Comme
Read Report ▸
PayPal logo
PYPL 90-day price performance2/1/2025

PayPal Stock Report

PayPal Holdings, Inc. is one of the world’s largest and oldest fintech companies having gotten its start in 1998. Originally a payment processing application named Confinity, the company will join forces with eBay in 2000 and then merge with the company in 2002. In 2008 Bill Me Later joined the company and eventually became Paypal Credit, the
Read Report ▸

Recent Stories:

A Whole Foods Market grocery store is in the Harlem neighborhood of New York City on March 3, 2023

2/5/2025
Amazon's Whole Foods asks agency to set aside the results of a union win at a Philadelphia store

Amazon-owned Whole Foods is asking the National Labor Relations Board to set aside the results of a union election in which the first group of the company’s employees voted in favor of collective bargaining. In a filing submitted to the agency this week, attorneys for Whole Foods Market argued the u...

President Donald Trump speaks to reporters as he signs executive orders in the Oval Office of the W…

2/4/2025
Trump’s tariff tactics carry higher economic risks than during his first term

When Donald Trump started the biggest trade war since the 1930s in his first term, his impulsive combination of threats and import taxes on U.S. trading partners created chaos, generated drama -- and drew criticism from mainstream economists who favor free trade

Republican presidential nominee former President Donald Trump, left, claps as Tesla and SpaceX CEO …

2/3/2025
Investors are betting Musk and Tesla will make a fortune under Trump even as threats mount

For Elon Musk fans, it’s the half a trillion-dollar bet.That is how much the stock market value of Tesla has rocketed since the presidential election, a vertiginous climb uninterrupted in recent days despite a disappointing financial report that would have sunk the stock of nearly any other company....

This February 9, 2024 photo shows a Walgreens in Bradenton, Fla. (AP Photo/Gene J. Puskar)

1/31/2025
Walgreens suspends dividend, breaking 90-plus year streak of shareholder payouts

Walgreens shares sank Friday, a day after the drugstore chain said it was suspending its dividend, breaking a streak of quarterly shareholder payouts that stretches back more than 90 years.The drugstore chain said late Thursday that it made the decision in an effort to strengthen its balance sheet a...

Read your StockReport.com newsletter to keep up with the hottest companies..